Get the Stockscreener App
1.41
11.88%
-0.19
Shuttle Pharmaceuticals Holdings Inc stock is traded at $1.41, with a volume of 174.14K.
It is down -11.88% in the last 24 hours and up +21.03% over the past month.
Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.
See More
Previous Close:
$1.60
Open:
$1.61
24h Volume:
174.14K
Relative Volume:
0.12
Market Cap:
$4.71M
Revenue:
-
Net Income/Loss:
$-7.35M
P/E Ratio:
-3.7105
EPS:
-0.38
Net Cash Flow:
$-5.48M
1W Performance:
-21.67%
1M Performance:
+21.03%
6M Performance:
+227.83%
1Y Performance:
+181.89%
1-Day Range:
$1.34
$1.70
1-Week Range:
$1.34
$1.98
52-Week Range:
$0.2872
$3.30
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
(240) 403-4212
Address
401 PROFESSIONAL DRIVE, GAITHERSBURG
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharma (SHPH) Stock Surges on Clinical Trial, Financing and Debt Elimination News - MSN
Shuttle Pharma Raises $4.5M for Clinical Trials - TipRanks
3 Penny Stocks to Watch Now, 10/31/24 - TipRanks
Shuttle Pharmaceuticals Successfully Doses First Patients in Phase 2 Clinical Trial for Glioblastoma Treatment - Defense World
Shuttle Pharma doses three subjects in Phase II glioblastoma treatment trial - Yahoo! Voices
"Stocks Key Trendlines: PRSO, PFIE, SHPH, BKYI, LIXT on the Verge of Breakthroughs" - Marketscreener.com
SHPHShuttle Pharmaceuticals Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of - GlobeNewswire
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - StockTitan
Shuttle Pharmaceuticals Holdings, Inc. Announces Pricing of $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - Benzinga
Shuttle Pharma Pays Off Senior Secured Convertible Note - GlobeNewswire
Micro Cap Company Is Soaring On Phase 2 Trial Update - MSN
Micro Cap Soaring On Phase 2 Trial Update - Invezz
TSX Industrials EW Index (TXIE) QuotePress Release - The Globe and Mail
US Stocks Mixed; McDonald's Posts Upbeat Earnings - Benzinga
Shuttle Pharmaceuticals Advances Phase 2 Glioblastoma Trial - TipRanks
Shuttle Pharma (SHPH) Stock Rises Pre-Market With Completion Site Enrollments - Stocks Telegraph
Shuttle Pharma Doses First Patients in Phase 2 Clinical - GlobeNewswire
Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma - Yahoo Finance
Why VF Corp Shares Are Trading Higher By Around 21%; Here Are 20 Stocks Moving Premarket - Benzinga
Shuttle Pharmaceuticals Shares Rise 63% on Drug-Study Site Update - MarketWatch
Shuttle Pharmaceuticals Advances Glioblastoma Clinical Trials - TipRanks
Shuttle Pharma Completes Clinical Trial Site Enrollment for - GlobeNewswire
Shuttle Pharma Completes Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - Marketscreener.com
Shuttle Pharmaceuticals to Present at ThinkEquity Conference - TipRanks
Shuttle Pharmaceuticals to Present at the 2024 ThinkEquity Conference on Wednesday, October 30, 2024 - GlobeNewswire
Shuttle Pharmaceuticals completes funding round, raises $790,000 By Investing.com - Investing.com Canada
Shuttle Pharmaceuticals completes funding round, raises $790,000 - Investing.com India
Shuttle Pharmaceuticals Holdings, Inc. announced that it expects to receive $1.3 million in funding - Marketscreener.com
Kingsoft Cloud Holdings Limited (NASDAQ:KC) Short Interest Update - Defense World
Office Properties Income Trust (NASDAQ:OPINL) Shares Up 3.9% – Here’s Why - Defense World
Munters Group AB (publ) (OTCMKTS:MMNNF) Stock Price Down 14.1% – Should You Sell? - Defense World
Shuttle Pharmaceuticals (NASDAQ:SHPH) Shares Up 7.2% – Should You Buy? - Defense World
Getlink: Shuttle Traffic in September 2024 - Yahoo Finance
SHPH stock touches 52-week low at $1.11 amid market challenges - Investing.com Australia
SHPH stock touches 52-week low at $1.11 amid market challenges By Investing.com - Investing.com South Africa
Stock Market Today: S&P 500 rides Nvidia-led tech surge to close higher - Investing.com
Union Pacific says FXE issuing some US-Mexico grain shuttle permits - Yahoo Finance
American Century Companies Inc. Lowers Stock Holdings in Paycom Software, Inc. (NYSE:PAYC) - Defense World
Ensign Peak Advisors Inc Sells 13,160 Shares of Owens Corning (NYSE:OC) - Defense World
Frank Rimerman Advisors LLC Takes $386,000 Position in Texas Roadhouse, Inc. (NASDAQ:TXRH) - Defense World
Skandinaviska Enskilda Banken AB publ Sells 2,013 Shares of Funko, Inc. (NASDAQ:FNKO) - Defense World
Thrivent Financial for Lutherans Purchases 32,464 Shares of Global X U.S. Infrastructure Development ETF (BATS:PAVE) - Defense World
Edison International (NYSE:EIX) PT Raised to $72.00 - Defense World
TransDigm Group Incorporated (NYSE:TDG) Stock Holdings Boosted by Zurich Insurance Group Ltd FI - Defense World
Shuttle Pharma advances glioblastoma treatment trial - Investing.com India
Shuttle Pharma advances glioblastoma treatment trial By Investing.com - Investing.com Canada
Shuttle Pharma Expands Clinical Trial Site Enrollment for - GlobeNewswire
Shuttle Pharma Expands Clinical Trial Site Enrollment for Phase 2 of Ropidoxuridine for Treatment of Patients with Glioblastoma - StockTitan
Shuttle Pharma faces Nasdaq delisting over equity shortfall - Investing.com
Investor Summit August 2024 Presentations Now Accessible for On-Demand Viewing - AccessWire
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.16%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):